337 related articles for article (PubMed ID: 31213910)
1. Apolipoprotein C1 (APOC1) promotes tumor progression via MAPK signaling pathways in colorectal cancer.
Ren H; Chen Z; Yang L; Xiong W; Yang H; Xu K; Zhai E; Ding L; He Y; Song X
Cancer Manag Res; 2019; 11():4917-4930. PubMed ID: 31213910
[No Abstract] [Full Text] [Related]
2. The Apolipoprotein C1 is involved in breast cancer progression via EMT and MAPK/JNK pathway.
Zhang H; Wang Y; Liu C; Li W; Zhou F; Wang X; Zheng J
Pathol Res Pract; 2022 Jan; 229():153746. PubMed ID: 34952429
[TBL] [Abstract][Full Text] [Related]
3. APOC1 predicts a worse prognosis for esophageal squamous cell carcinoma and is associated with tumor immune infiltration during tumorigenesis.
Cao X; Wu B; Guo S; Zhong W; Zhu S; Zhang Z; Gu L; Li H
Pathol Oncol Res; 2023; 29():1610976. PubMed ID: 36969562
[No Abstract] [Full Text] [Related]
4. UBN2 promotes tumor progression via the Ras/MAPK pathway and predicts poor prognosis in colorectal cancer.
Zhao YL; Zhong SR; Zhang SH; Bi JX; Xiao ZY; Wang SY; Jiao HL; Zhang D; Qiu JF; Zhang LJ; Huang CM; Chen XL; Ding YQ; Ye YP; Liang L; Liao WT
Cancer Cell Int; 2019; 19():126. PubMed ID: 31110467
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein C1 promotes tumor progression in gastric cancer.
Gu Q; Zhan T; Guan X; Lai C; Lu NA; Wang G; Xu L; Gao X; Zhang J
Oncol Res; 2023; 31(3):287-297. PubMed ID: 37305389
[TBL] [Abstract][Full Text] [Related]
6. Expression of ubiquitin-conjugating enzyme E2T in colorectal cancers and clinical implications.
Wu X; Liu G; Liu R; He J; Wang G; Zhang H; Liu T; Bai J; Cheng N; Qiu J
Oncol Lett; 2020 Nov; 20(5):275. PubMed ID: 33014154
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of APOC1 Promotes Colorectal Cancer Progression and Serves as a Potential Therapeutic Target Based on Bioinformatics Analysis.
Tang W; Liu H; Li X; Ooi TC; Rajab NF; Cao H; Sharif R
J Oncol; 2023; 2023():2611105. PubMed ID: 36908705
[TBL] [Abstract][Full Text] [Related]
8. Decreased APOC1 expression inhibited cancer progression and was associated with better prognosis and immune microenvironment in esophageal cancer.
Guo Q; Liu XL; Jiang N; Zhang WJ; Guo SW; Yang H; Ji YM; Zhou J; Guo JL; Zhang J; Liu HS
Am J Cancer Res; 2022; 12(11):4904-4929. PubMed ID: 36504892
[TBL] [Abstract][Full Text] [Related]
9. Granulin epithelin precursor promotes colorectal carcinogenesis by activating MARK/ERK pathway.
Pan Y; Cheung ST; Tong JHM; Tin KY; Kang W; Lung RWM; Wu F; Li H; Ng SSM; Mak TWC; To KF; Chan AWH
J Transl Med; 2018 Jun; 16(1):150. PubMed ID: 29866109
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.
Cui Y; Miao C; Hou C; Wang Z; Liu B
Front Oncol; 2020; 10():1436. PubMed ID: 32974161
[No Abstract] [Full Text] [Related]
11. Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Cervical Cancer.
Shi X; Wang J; Dai S; Qin L; Zhou J; Chen Y
Onco Targets Ther; 2020; 13():12881-12891. PubMed ID: 33364782
[TBL] [Abstract][Full Text] [Related]
12. TLE3 represses colorectal cancer proliferation by inhibiting MAPK and AKT signaling pathways.
Yang RW; Zeng YY; Wei WT; Cui YM; Sun HY; Cai YL; Nian XX; Hu YT; Quan YP; Jiang SL; Wang M; Zhao YL; Qiu JF; Li MX; Zhang JH; He MR; Liang L; Ding YQ; Liao WT
J Exp Clin Cancer Res; 2016 Sep; 35(1):152. PubMed ID: 27669982
[TBL] [Abstract][Full Text] [Related]
13. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
14. Interferon-induced transmembrane protein 2 is a prognostic marker in colorectal cancer and promotes its progression by activating the PI3K/AKT pathway.
Liu Y; Liang J; Li X; Huang J; Huang J; Wang J
Discov Oncol; 2024 May; 15(1):191. PubMed ID: 38802621
[TBL] [Abstract][Full Text] [Related]
15. [Role of allograft inflammatory factor-1 in regulating the proliferation, migration and apoptosis of colorectal cancer cells].
Ai XL; Yao F; Wang XJ; Duan DB; Li K; Hu ZY; Yin G; Wang M; Wu BY
Nan Fang Yi Ke Da Xue Xue Bao; 2018 May; 38(5):511-519. PubMed ID: 29891445
[TBL] [Abstract][Full Text] [Related]
16. CCDC68 predicts poor prognosis in patients with colorectal cancer: a study based on TCGA data.
Zhang W; Xu TT; An ZT; Wei LF; Gu C; Li H; Tian YZ
J Gastrointest Oncol; 2022 Apr; 13(2):657-671. PubMed ID: 35557589
[TBL] [Abstract][Full Text] [Related]
17. High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-κB/p53-apoptosis signaling pathway in colorectal cancer.
Yi W; Xiao E; Ding R; Luo P; Yang Y
Oncol Rep; 2016 Dec; 36(6):3145-3153. PubMed ID: 27748871
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis reveals TSPEAR as a prognostic biomarker in colorectal cancer.
Xue D; Peng H; Li Z; Xu J; Ma H; Dang Y; Li F; Wang G; Sun Q
J Cancer; 2024; 15(3):809-824. PubMed ID: 38213725
[No Abstract] [Full Text] [Related]
19. STING promotes proliferation and induces drug resistance in colorectal cancer by regulating the AMPK-mTOR pathway.
Yao H; Wang S; Zhou X; Sun J; Zhou G; Zhou D; Chen G; Shi X; Chen J; Shi B; Tai Q; Mi X; Sun L; Yao Y; He S
J Gastrointest Oncol; 2022 Oct; 13(5):2458-2471. PubMed ID: 36388670
[TBL] [Abstract][Full Text] [Related]
20. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]